Spots Global Cancer Trial Database for mesna
Every month we try and update this database with for mesna cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | NCT01331590 | Precursor Cell ... | G-CSF Ifosfamide Etoposide Dexamethasone Mesna | 18 Years - | Washington University School of Medicine | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | NCT00002549 | Leukemia | filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | NCT00002785 | Leukemia | filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... mercaptopurine mesna methotrexate methylprednisol... pegaspargase prednisone therapeutic hyd... vincristine sul... allogeneic bone... low-LET cobalt-... low-LET photon ... | - 1 Year | Children's Oncology Group | |
| A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma | NCT00001300 | Sarcoma | doxorubicin ifosfamide mesna | - | National Institutes of Health Clinical Center (CC) | |
| Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia | NCT04881240 | Acute Lymphobla... Acute Lymphobla... Pediatric ALL | CD19-CAR(Mem) T... Cyclophosphamid... Fludarabine Mesna CliniMACS Leukapheresis | - 21 Years | St. Jude Children's Research Hospital | |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors | NCT00066482 | Childhood Germ ... Extragonadal Ge... | bleomycin sulfa... filgrastim cisplatin cyclophosphamid... etoposide conventional su... MESNA | - 21 Years | Children's Oncology Group | |
| Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma | NCT05470283 | Tumor Metastatic Mela... Melanoma | OBX-115 Acetazolamide Cyclophosphamid... Furosemide Mesna Fludarabine Pho... | 18 Years - | M.D. Anderson Cancer Center | |
| Fosaprepitant in Patients Receiving Ifosfamide-based Regimen | NCT01490060 | Sarcoma Chemotherapy-in... Effects of Chem... Adverse Effects... | Fosaprepitant Dexamethasone 5HT3 receptor a... Ifosfamide-base... Doxorubicin Mesna Ifosfamide Vincristine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Randomized Double Cord Blood Transplant Study | NCT00067002 | Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Lymphoma, Non-H... | Expanded alloge... One Unmanipulat... Rituxan Melphalan Thiotepa Fludarabine Cyclophosphamid... Mesna Total body irra... | 1 Month - 80 Years | M.D. Anderson Cancer Center | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT00941928 | Leukemia Pediatric Cance... | Epratuzumab Fludarabine Cyclophosphamid... Mesna Infusion of NK ... Interleukin-2 | - | M.D. Anderson Cancer Center | |
| Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University | |
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT05032183 | Recurrent Adult... Recurrent B Acu... Recurrent T Acu... Refractory B Ac... Refractory Lymp... Refractory T Ac... | Cyclophosphamid... Cytarabine Dexamethasone Filgrastim-sndz Leucovorin Mercaptopurine Mesna Methotrexate Pegfilgrastim Prednisone Rituximab Tagraxofusp-erz... Vincristine | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy | NCT01807611 | Leukemia Lymphoma | Total Lymphoid ... Fludarabine Cyclophosphamid... Thiotepa Melphalan HPC,A Infusion TC-NK Infusion G-CSF Mesna CliniMACS Mycophenolate m... | - 21 Years | St. Jude Children's Research Hospital | |
| Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission | NCT00667927 | Acute Myeloid L... | Busulfan Cyclophosphamid... Mesna | 1 Year - 18 Years | St. Jude Children's Research Hospital | |
| Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | NCT00439361 | Hodgkin Lymphom... Lymphoma | Bortezomib Carboplatin Etoposide Ifosfamide Mesna | 16 Years - | M.D. Anderson Cancer Center | |
| A Study of N9 Chemotherapy in Children With Neuroblastoma | NCT04947501 | Neuroblastoma Pediatric Cance... | Cyclophosphamid... Topotecan Vincristine Doxorubicin Ifosfamide Etoposide Carboplatin Mesna | 1 Year - 19 Years | Memorial Sloan Kettering Cancer Center | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | NCT01783535 | Retinoblastoma | vincristine topotecan filgrastim PEG-filgrastim carboplatin focal therapy etoposide cyclophosphamid... MESNA doxorubicin enucleation external beam r... | - | St. Jude Children's Research Hospital | |
| A Study of N9 Chemotherapy in Children With Neuroblastoma | NCT04947501 | Neuroblastoma Pediatric Cance... | Cyclophosphamid... Topotecan Vincristine Doxorubicin Ifosfamide Etoposide Carboplatin Mesna | 1 Year - 19 Years | Memorial Sloan Kettering Cancer Center | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group | |
| Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia | NCT00002704 | Leukemia | filgrastim asparaginase cyclophosphamid... daunorubicin hy... dexamethasone etoposide leucovorin calc... liposomal cytar... mercaptopurine mesna methotrexate therapeutic hyd... thiotepa vincristine sul... low-LET electro... low-LET photon ... | - 20 Years | National Cancer Institute (NCI) | |
| Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | NCT00673179 | Osteosarcoma | Doxorubicin Cisplatin Methotrexate Leucovorin Dexrazoxane Ifosfamide Questionnaire Gemcitabine Sargramostim Surgery Mesna | 5 Years - 40 Years | M.D. Anderson Cancer Center | |
| Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | NCT00126191 | Burkitt Lymphom... Non-Hodgkins Ly... Atypical Burkit... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Methotrexate Leucovorin Ifosfamide Etoposide Cytarabine Mesna | 18 Years - | Dana-Farber Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | NCT00002494 | Leukemia Lymphoma | cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... mesna methotrexate prednisone therapeutic hyd... vincristine sul... low-LET cobalt-... low-LET photon ... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) | NCT02702960 | Fibrolamellar H... Hepatocellular ... Hepatocellular ... | living related ... Total body irra... Bone marrow tra... Cyclophosphamid... Mesna Filgrastim Tacrolimus mycophenolate m... Prednisone Antithymocyte g... fludarabine | 16 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) | NCT03821610 | Acute Lymphobla... | Fludarabine Melphalan Alemtuzumab Cyclophosphamid... Mesna Total Body Irra... | 40 Years - 70 Years | University of Birmingham | |
| Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia | NCT00002704 | Leukemia | filgrastim asparaginase cyclophosphamid... daunorubicin hy... dexamethasone etoposide leucovorin calc... liposomal cytar... mercaptopurine mesna methotrexate therapeutic hyd... thiotepa vincristine sul... low-LET electro... low-LET photon ... | - 20 Years | National Cancer Institute (NCI) | |
| Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide | NCT00800839 | Hematologic Dis... Leukemia Lymphoma Myeloma | Busulfan Fludarabine Cyclophosphamid... | 6 Months - 75 Years | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | NCT00002822 | Lung Cancer | carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide mesna vincristine sul... radiation thera... | - | National Cancer Institute (NCI) | |
| A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss | NCT05382338 | Medulloblastoma | Cisplatin Cyclophosphamid... Lomustine Mesna Quality-of-Life... Radiation Thera... Sodium Thiosulf... Survey Administ... Vincristine | 3 Years - 21 Years | Children's Oncology Group | |
| TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma | NCT02652468 | Lymphoma | Fludarabine Pho... Mesna Cyclophosphamid... Total nodal irr... T Cell-Depleted... Allogeneic Hema... Peripheral Bloo... Mycophenolate M... Tacrolimus Rituximab | 18 Years - 75 Years | University of Wisconsin, Madison | |
| Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) | NCT02408042 | Lymphoma Hodgkin's Lymph... Non-hodgkin's L... | Pembrolizumab Etoposide Ifosfamide Mesna Carboplatin Brentuximab ved... Rituximab | 18 Years - | Western Regional Medical Center | |
| Cryopreserved MMUD BM With PTCy for Hematologic Malignancies | NCT05170828 | Acute Leukemia Myelodysplastic... T-lymphoblastic... Acute Lymphocyt... Acute Myeloid L... Acute Biphenoty... Acute Undiffere... | Cyclophosphamid... Fludarabine Total Body Irra... Busulfan Mesna Sirolimus Mycophenolate M... Filgrastim Cyclophosphamid... Bone Marrow Tra... | 18 Years - 70 Years | Ossium Health, Inc. | |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | NCT00002565 | Lymphoma | bleomycin sulfa... CHOP regimen cisplatin cyclophosphamid... cytarabine doxorubicin hyd... etoposide idarubicin ifosfamide mesna methylprednisol... mitoxantrone hy... prednisone vincristine sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients | NCT01481272 | Diffuse Large B... | Ofatumumab Etoposide Ifosfamid Mesna Cytarabine Methotrexate Leukovorin Granulocyte-Col... | 18 Years - | Polish Lymphoma Research Group | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | NCT00002549 | Leukemia | filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - 60 Years | National Cancer Institute (NCI) | |
| Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies | NCT04959175 | Hematologic Neo... | Mycophenolate M... Allogeneic HSCT Fludarabine Sirolimus Filgrastim Cyclophosphamid... Mesna Total Body Irra... | 12 Years - 85 Years | National Institutes of Health Clinical Center (CC) | |
| A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss | NCT05382338 | Medulloblastoma | Cisplatin Cyclophosphamid... Lomustine Mesna Quality-of-Life... Radiation Thera... Sodium Thiosulf... Survey Administ... Vincristine | 3 Years - 21 Years | Children's Oncology Group | |
| Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients | NCT01481272 | Diffuse Large B... | Ofatumumab Etoposide Ifosfamid Mesna Cytarabine Methotrexate Leukovorin Granulocyte-Col... | 18 Years - | Polish Lymphoma Research Group | |
| Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer | NCT00091611 | Kidney Neoplasm... | IL-2 (interleuk... OKT3 Cyclophosphamid... Fludarabine Mesna | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | NCT00002510 | Lymphoma | filgrastim cyclophosphamid... etoposide mesna peripheral bloo... radiation thera... | 16 Years - 65 Years | Temple University | |
| Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma | NCT00878254 | Mantle-Cell Lym... | G-CSF Rituximab Cyclophosphamid... Cytarabine Doxorubicin Etoposide Ifosfamide Leucovorin Mesna Methotrexate Vincristine | 18 Years - | University of Miami | |
| Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma | NCT06190249 | Stage IIIB Mela... Stage IIIC Mela... Stage IIID Mela... | LN-144 Cyclophosphamid... Mesna Fludarabine Interleukin-2 (... Pembrolizumab | 18 Years - | Case Comprehensive Cancer Center | |
| Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release | NCT01205503 | Breast Cancer Non-Hodgkin's L... | Mesna Saline Doxorubicin Cyclophosphamid... | 18 Years - | University of Kentucky | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | NCT00002804 | Sarcoma | filgrastim doxorubicin hyd... ifosfamide mesna vincristine sul... conventional su... brachytherapy low-LET cobalt-... low-LET electro... low-LET photon ... | - 21 Years | Children's Oncology Group | |
| HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis | NCT06001385 | Acute Lymphobla... Acute Myeloid L... Acute Leukemia Myelodysplastic... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Lymphoma Chronic Myelomo... Pro-Lymphocytic... Myelofibrosis | Busulfan Fludarabine PBSC Hematopoie... Post-Transplant... Mesna Tacrolimus Mycophenolate M... Patient Reporte... Melphalan Total-body irra... Cyclophosphamid... | 18 Years - | Center for International Blood and Marrow Transplant Research | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas | NCT00165139 | Neuroblastoma Ewings Sarcoma Non-rhabdomyosa... | Vincristine Cyclophosphamid... Adriamycin Etoposide (VP-1... Cisplatin Carboplatin Melphalan Ifosfamide G-CSF (granuloc... Mesna | - 19 Years | Dana-Farber Cancer Institute | |
| Chemotherapy in Treating Patients With Retinoblastoma | NCT00002675 | Retinoblastoma | filgrastim carboplatin cisplatin cyclophosphamid... etoposide mesna vincristine sul... | - 17 Years | Memorial Sloan Kettering Cancer Center | |
| Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer | NCT00002628 | Breast Cancer | filgrastim carboplatin cyclophosphamid... mesna paclitaxel peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia | NCT03573700 | Acute Lymphobla... Acute Lymphobla... | Cyclophosphamid... Fludarabine Mesna CliniMACS CD19- specific ... | - 21 Years | St. Jude Children's Research Hospital | |
| Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | NCT00002961 | Leukemia | cyclophosphamid... cyclosporine etoposide methotrexate allogeneic bone... Total Body Irra... Busulfan Mesna Radiation | - 21 Years | Children's Hospital of Philadelphia | |
| Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma | NCT00698009 | Neuroblastoma | Fludarabine Cyclophosphamid... Natural Killer ... Mesna Interleukin-2 | - | M.D. Anderson Cancer Center | |
| Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | NCT00002961 | Leukemia | cyclophosphamid... cyclosporine etoposide methotrexate allogeneic bone... Total Body Irra... Busulfan Mesna Radiation | - 21 Years | Children's Hospital of Philadelphia | |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE | NCT00578461 | Leukemia Cancer Lymphoma Lymphoma, Hodgk... Lymphoma, Non-H... | Ara C Mesna Cyclophosphamid... TBI-Total Body ... | - 64 Years | Baylor College of Medicine | |
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | NCT00432094 | Childhood Germ ... Ovarian Cancer Teratoma | carboplatin etoposide ifosfamide paclitaxel thiotepa autologous hema... Mesna filgrastim | 10 Years - 69 Years | Masonic Cancer Center, University of Minnesota | |
| Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source | NCT02167958 | Leukemia MDS Myelofibrosis Lymphoma | Fludarabine Cyclophosphamid... Mesna Total Body Irra... Hematopoietic s... Tacrolimus Mycophenolate G-CSF | 18 Years - 70 Years | University of Pittsburgh | |
| Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer | NCT00002628 | Breast Cancer | filgrastim carboplatin cyclophosphamid... mesna paclitaxel peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| CYNK-101 in Combination With Trastuzumab and Pembrolizumab in Patients With Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma | NCT05207722 | Metastatic HER2... | CYNK-101 Pembrolizumab Trastuzumab Recombinant Hum... Cyclophosphamid... Fludarabine Mesna | 18 Years - 75 Years | Celularity Incorporated | |
| Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | NCT01783535 | Retinoblastoma | vincristine topotecan filgrastim PEG-filgrastim carboplatin focal therapy etoposide cyclophosphamid... MESNA doxorubicin enucleation external beam r... | - | St. Jude Children's Research Hospital | |
| Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | NCT00002634 | Neuroblastoma | filgrastim monoclonal anti... cisplatin cyclophosphamid... doxorubicin hyd... etoposide mesna perfosfamide vincristine sul... autologous bone... in vitro-treate... low-LET cobalt-... low-LET photon ... radioisotope th... | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma | NCT06190249 | Stage IIIB Mela... Stage IIIC Mela... Stage IIID Mela... | LN-144 Cyclophosphamid... Mesna Fludarabine Interleukin-2 (... Pembrolizumab | 18 Years - | Case Comprehensive Cancer Center | |
| IS-free Treg HaploHCT | NCT04678401 | Stem Cell Trans... Graft Vs Host D... Myeloid Leukemi... Myeloid Leukemi... Myelodysplastic... | Radiation Fludarabine Thiotepa Cyclophosphamid... Mesna Treg-enriched d... Unmodified dono... CD34+ Haplo Per... | 18 Years - 65 Years | Dana-Farber Cancer Institute | |
| Study of Bortezomib in Combination With Cyclophosphamide and Rituximab | NCT00958256 | Mantle Cell Lym... Lymphoma | Bortezomib Rituximab Cyclophosphamid... Mesna G-CSF | 18 Years - 85 Years | M.D. Anderson Cancer Center | |
| Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen | NCT02199041 | Hematological M... | Cyclophosphamid... Thiotepa Fludarabine Melphalan Mesna G-CSF Mycophenolate m... Tacrolimus Methylprednisol... Total lymphoid ... Lymphocyte infu... CliniMACS | - 21 Years | St. Jude Children's Research Hospital | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| IS-free Treg HaploHCT | NCT04678401 | Stem Cell Trans... Graft Vs Host D... Myeloid Leukemi... Myeloid Leukemi... Myelodysplastic... | Radiation Fludarabine Thiotepa Cyclophosphamid... Mesna Treg-enriched d... Unmodified dono... CD34+ Haplo Per... | 18 Years - 65 Years | Dana-Farber Cancer Institute | |
| Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | NCT02436707 | Lymphoma | Ibrutinib Rituximab Gemcitabine Dexamethasone Cisplatin Mesna Cyclophosphamid... Etoposide G-CSF Selinexor | 16 Years - 65 Years | Canadian Cancer Trials Group | |
| Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma | NCT01169636 | Hodgkin's Lymph... | Panobinostat Ifosfamide Mesna Carboplatin Etoposide Pegfilgrastim | 16 Years - | M.D. Anderson Cancer Center | |
| Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas | NCT00165139 | Neuroblastoma Ewings Sarcoma Non-rhabdomyosa... | Vincristine Cyclophosphamid... Adriamycin Etoposide (VP-1... Cisplatin Carboplatin Melphalan Ifosfamide G-CSF (granuloc... Mesna | - 19 Years | Dana-Farber Cancer Institute | |
| Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma | NCT00002804 | Sarcoma | filgrastim doxorubicin hyd... ifosfamide mesna vincristine sul... conventional su... brachytherapy low-LET cobalt-... low-LET electro... low-LET photon ... | - 21 Years | Children's Oncology Group | |
| Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy | NCT02732015 | Locally Advance... | Dexamethasone Doxorubicin Fosaprepitant D... Ifosfamide Laboratory Biom... Mesna Ondansetron Questionnaire A... Rolapitant Hydr... Vincristine Sul... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Umbilical Cord Blood Transplantation From Unrelated Donors | NCT03016806 | Acute Leukemia Immune Deficien... Congenital Hema... Metabolism Diso... Aplastic Anemia Myelodysplastic... Chronic Leukemi... Lymphoma Multiple Myelom... Solid Tumor | Total Body Irra... Total Body Irra... Cyclophosphamid... Mesna Cord Blood Infu... Busulfan Fludarabine Melphalan | 2 Months - 75 Years | University of Rochester |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
